Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01136382 · ClinicalTrials.gov registry record · Phase 2
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
A Phase 2 study, sponsored by AstraZeneca.
- Completed
- Registry status
- Phase 2
- Development phase
- 304
- Enrollment target
NCT01136382 is a Phase 2 study that has completed, run by AstraZeneca. The registered enrollment target is 304 participants.
The verdict
NCT01136382, a Phase 2 study, has completed, sponsored by AstraZeneca.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 304 participants
- Enrollment target
Study Summary
This purpose of the study is to investigate if budesonide pMDI 160 �g twice a day during 6 weeks is effective and safe in treating asthmatic children aged 6 to \<12 years
Interventions
- DRUG placebo
- DRUG budesonide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 304 participants |
| Start Date | 2010-07 |
| Est. Completion | 2013-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01136382
The ClinicalTrials.gov registry entry for NCT01136382 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 304 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AstraZeneca, which has 1,285 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT01136382 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01136382 about?
NCT01136382 is a clinical study titled "A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo". This purpose of the study is to investigate if budesonide pMDI 160 �g twice a day during 6 weeks is effective and safe in treating asthmatic children aged 6 to \<12 years
What is the current status of trial NCT01136382?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 304 participants. The study started on 2010-07. Estimated completion is 2013-04.
What interventions are being tested in trial NCT01136382?
The interventions under investigation include: placebo (DRUG), budesonide (DRUG).
Who is sponsoring clinical trial NCT01136382?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.